79 related articles for article (PubMed ID: 16307714)
1. An assay for the determination of biologically active bone morphogenetic proteins using cells transfected with an inhibitor of differentiation promoter-luciferase construct.
Logeart-Avramoglou D; Bourguignon M; Oudina K; Ten Dijke P; Petite H
Anal Biochem; 2006 Feb; 349(1):78-86. PubMed ID: 16307714
[TBL] [Abstract][Full Text] [Related]
2. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.
Abe M; Harpel JG; Metz CN; Nunes I; Loskutoff DJ; Rifkin DB
Anal Biochem; 1994 Feb; 216(2):276-84. PubMed ID: 8179182
[TBL] [Abstract][Full Text] [Related]
3. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
4. A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
Zilberberg L; ten Dijke P; Sakai LY; Rifkin DB
BMC Cell Biol; 2007 Sep; 8():41. PubMed ID: 17880711
[TBL] [Abstract][Full Text] [Related]
5. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
7. Identification of an osteogenic protein-1 responsive element in the aggrecan promoter.
Yeh LC; Lee JC
Biochem Biophys Res Commun; 2004 Oct; 323(1):223-8. PubMed ID: 15351725
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor-9 has divergent effects on proliferation and steroidogenesis of bovine granulosa cells.
Spicer LJ; Aad PY; Allen D; Mazerbourg S; Hsueh AJ
J Endocrinol; 2006 May; 189(2):329-39. PubMed ID: 16648300
[TBL] [Abstract][Full Text] [Related]
9. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter.
Pan Q; Yu Y; Chen Q; Li C; Wu H; Wan Y; Ma J; Sun F
J Cell Physiol; 2008 Oct; 217(1):228-41. PubMed ID: 18506848
[TBL] [Abstract][Full Text] [Related]
10. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
11. Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9.
Truksa J; Peng H; Lee P; Beutler E
Br J Haematol; 2007 Oct; 139(1):138-47. PubMed ID: 17854319
[TBL] [Abstract][Full Text] [Related]
12. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells.
Seib FP; Franke M; Jing D; Werner C; Bornhäuser M
Eur J Cell Biol; 2009 May; 88(5):257-71. PubMed ID: 19303661
[TBL] [Abstract][Full Text] [Related]
13. BMP signaling regulates PGC numbers and motility in organ culture.
Dudley BM; Runyan C; Takeuchi Y; Schaible K; Molyneaux K
Mech Dev; 2007 Jan; 124(1):68-77. PubMed ID: 17112707
[TBL] [Abstract][Full Text] [Related]
14. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
15. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.
Miyoshi T; Otsuka F; Suzuki J; Takeda M; Inagaki K; Kano Y; Otani H; Mimura Y; Ogura T; Makino H
Biol Reprod; 2006 Jun; 74(6):1073-82. PubMed ID: 16436528
[TBL] [Abstract][Full Text] [Related]
16. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
Behnam K; Murray SS; Brochmann EJ
Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
[TBL] [Abstract][Full Text] [Related]
17. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
18. BMP-4 treatment of C3H10T1/2 stem cells blocks expression of MMP-3 and MMP-13.
Otto TC; Bowers RR; Lane MD
Biochem Biophys Res Commun; 2007 Feb; 353(4):1097-104. PubMed ID: 17204246
[TBL] [Abstract][Full Text] [Related]
19. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.
Zachos TA; Shields KM; Bertone AL
J Orthop Res; 2006 Jun; 24(6):1279-91. PubMed ID: 16649180
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of cell lines for high-throughput screening of human neuromedin U receptor subtype 2 specific agonists using a luciferase reporter gene assay.
Li X; Shen F; Zhang Y; Zhu J; Huang L; Shi Q
Eur J Pharm Biopharm; 2007 Aug; 67(1):284-92. PubMed ID: 17337170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
